DNVYX
Price
$28.25
Change
-$0.22 (-0.77%)
Updated
Aug 15 closing price
Net Assets
6.68B
DODGX
Price
$273.40
Change
+$0.29 (+0.11%)
Updated
Aug 15 closing price
Net Assets
116.17B
Interact to see
Advertisement

DNVYX vs DODGX

Header iconDNVYX vs DODGX Comparison
Open Charts DNVYX vs DODGXBanner chart's image
Davis NY Venture Y
Price$28.25
Change-$0.22 (-0.77%)
VolumeN/A
Net Assets6.68B
Dodge & Cox Stock I
Price$273.40
Change+$0.29 (+0.11%)
VolumeN/A
Net Assets116.17B
DNVYX vs DODGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNVYX vs. DODGX commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNVYX is a StrongBuy and DODGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 116B vs. DNVYX (6.68B). DNVYX pays higher dividends than DODGX: DNVYX (1.73) vs DODGX (1.39). DNVYX was incepted earlier than DODGX: DNVYX (29 years) vs DODGX (61 years). DNVYX (0.67) is less costly to investors than DODGX (0.51). DNVYX is a more actively managed with annual turnover of: 17.00 vs. DODGX (15.00). DODGX has a lower initial minimum investment than DNVYX: DODGX (2500) vs DNVYX (5000000). DODGX annual gain was more profitable for investors over the last year : 4.67 vs. DNVYX (-1.31). DODGX return over 5 years is better than : 67.01 vs. DNVYX (4.61).
DNVYXDODGXDNVYX / DODGX
Total Expense Ratio0.670.51131%
Annual Report Gross Expense Ratio0.670.51131%
Fund Existence29 years61 years-
Gain YTD5.6127.19778%
Front LoadN/AN/A-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.68B116B6%
Annual Yield % from dividends1.731.39124%
Returns for 1 year-1.314.67-28%
Returns for 3 years18.3920.8388%
Returns for 5 years4.6167.017%
Returns for 10 years-13.5162.58-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLHIX27.290.35
+1.30%
Virtus KAR Health Sciences Inst
PABGX203.64-0.19
-0.09%
T. Rowe Price Blue Chip Growth Advisor
IUTCX28.21-0.14
-0.49%
Invesco Dividend Income C
AMFEX19.64-0.11
-0.56%
AAMA Equity
GSMCX38.41-0.23
-0.60%
Goldman Sachs Mid Cap Value Instl